Form S-3 PLASMATECH BIOPHARMACEUT
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St set for higher open after retail earnings; Moderna soars
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Tech selloff weighs down Wall Street as bond yields climb
- Marvell issues Google warrant tied to custom chip deal
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
PlasmaTech Biopharma (PTBI) Posts Markedly Better Q1 Results
May 15, 2015 8:07 AM EDTPlasmaTech Biopharma (NASDAQ: PTBI) reported Q1 EPS of ($0.10), versus ($3.06) reported last year. Revenue for the quarter came in at $258 thousand, versus $208 thousand reported last year.
For earnings history and earnings-related data on PlasmaTech Biopharma (PTBI) click here.
... MorePlasmaTech Biopharmaceuticals (PTBI) Files 1.93M Common Shelf for Shareholders
May 15, 2015 6:11 AM EDTPlasmaTech Biopharmaceuticals (NASDAQ: PTBI) filed a registration with the U.S. SEC to sell up to 1,925,000 Shares of Common Stock on behalf of Selling Shareholders.
... More